Westpac Banking Corp Incyte Corp Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Incyte Corp stock. As of the latest transaction made, Westpac Banking Corp holds 1,850 shares of INCY stock, worth $130,499. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,850

Previous 1,850 -0.0%

Holding current value

$130,499

Previous $112 Million 9.04%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $91,561 - $114,048	1,789 Added 2932.79%	1,850 $112 Million
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $91,561 - $114,048	-1,789 Reduced 96.7%	61 $112 Million
Q1 2024 May 09, 2024	SELL	$56.55 - $66.59 $70,800 - $83,370	-1,252 Reduced 40.36%	1,850 $105 Million
Q4 2023 Feb 08, 2024	BUY	$52.16 - $64.19 $63,009 - $77,541	1,208 Added 63.78%	3,102 $195 Million
Q3 2023 Nov 09, 2023	BUY	$57.77 - $65.93 $22,645 - $25,844	392 Added 26.1%	1,894 $109 Million
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $973,554 - $1.21 Million	-15,973 Reduced 91.4%	1,502 $93.5 Million
Q1 2023 May 03, 2023	BUY	$70.23 - $86.01 $190,042 - $232,743	2,706 Added 18.32%	17,475 $1.26 Billion
Q4 2022 Feb 06, 2023	BUY	$67.18 - $84.11 $37,217 - $46,596	554 Added 3.9%	14,769 $1.19 Billion
Q3 2022 Nov 08, 2022	SELL	$66.18 - $82.86 $60,753 - $76,065	-918 Reduced 6.07%	14,215 $947 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $54,863 - $68,956	829 Added 5.8%	15,133 $1.15 Billion
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $54,334 - $65,601	823 Added 6.1%	14,304 $0
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $13,554 - $15,859	214 Added 1.61%	13,481 $990 Million
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $1.49 Million - $2.19 Million	-20,061 Reduced 60.19%	13,267 $0
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $821,403 - $1.12 Million	13,001 Added 63.96%	33,328 $0
Q4 2019 Feb 11, 2020	BUY	$73.04 - $95.72 $334,742 - $438,684	4,583 Added 29.11%	20,327 $0
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $96,486 - $114,639	-1,325 Reduced 7.76%	15,744 $0
Q2 2019 Aug 01, 2019	SELL	$73.52 - $88.7 $3.88 Million - $4.68 Million	-52,729 Reduced 75.55%	17,069 $0
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $65,593 - $90,991	1,032 Added 1.5%	69,798 $0
Q4 2018 Feb 07, 2019	BUY	$58.5 - $69.94 $5,850 - $6,994	100 Added 0.15%	68,766 $0
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $3.59 Million - $4.31 Million	58,061 Added 547.49%	68,666 $0
Q3 2017 Oct 30, 2017	BUY	$109.15 - $138.27 $1.16 Million - $1.47 Million	10,605	10,605 $0

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Incyte Corp Transaction History